HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap USD
Fund
ISIN LU1540961759 / Valor 35003342
NAV (2024-11-29)
USD 478.43-0.09%
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap USD
UMushroom community rating:
0.00
0 votes
No rating yet
NegativeNeutralPositive
General Objective
The main investment objective of the fund is to achieve long-term capital growth and generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index. The fund invests mainly in equities and equity-related securities of companies worldwide that are active in the biotechnology and (bio)pharmaceutical industries.
Fund Exposure
The fund is exposed to companies mainly active in the biotechnology and (bio)pharmaceutical industries, with a focus on small and mid-sized companies in the biotechnology sector. The fund aims to outperform the NASDAQ Biotechnology Index through its investments in equities and equity-related securities.
Risks
Investing in the fund involves risks such as market risk, sector risk, and currency risk. The value of investments can go up or down, and there is no guarantee that the investment objective will be achieved. Past performance is not indicative of future results, and investors should carefully consider the risks involved before investing in the fund.